发明授权
US09155705B2 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
有权
DPP-IV抑制剂与另一种抗糖尿病药物组合，包含这些制剂的片剂，其用途及其制备方法
- 专利标题： DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
- 专利标题（中）： DPP-IV抑制剂与另一种抗糖尿病药物组合，包含这些制剂的片剂，其用途及其制备方法
-
申请号： US12935634申请日： 2009-04-02
-
公开(公告)号： US09155705B2公开(公告)日： 2015-10-13
- 发明人: Thomas Friedl , Michael Braun , Kenji Egusa , Hikaru Fujita , Megumi Maruyama , Takaaki Nishioka
- 申请人： Thomas Friedl , Michael Braun , Kenji Egusa , Hikaru Fujita , Megumi Maruyama , Takaaki Nishioka
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Timothy X. Witkowski
- 优先权： EP08154039 20080403
- 国际申请： PCT/EP2009/053978 WO 20090402
- 国际公布： WO2009/121945 WO 20091008
- 主分类号： A61K45/06
- IPC分类号： A61K45/06 ; A61K9/16 ; A61K31/522 ; A61K9/20 ; A61K9/24 ; A61K31/155
摘要：
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
公开/授权文献
信息查询
